Questions: The nurse understands which medication may cause gynecological malignancies females?
Oxytocin
Raloxifene
Thalidomide
Diethylstilbestrol
Transcript text: The nurse understands which medication may cause gynecological malignancies females?
Oxytocin
Raloxifene
Thalidomide
Diethylstilbestrol
Solution
The answer is the fourth one: Diethylstilbestrol.
Explanation for each option:
Oxytocin: This is a hormone commonly used to induce labor or control bleeding after childbirth. It is not associated with causing gynecological malignancies.
Raloxifene: This medication is used to prevent osteoporosis in postmenopausal women and may reduce the risk of breast cancer. It is not known to cause gynecological malignancies.
Thalidomide: This drug is used to treat certain cancers and skin conditions. It is infamous for causing birth defects when taken during pregnancy but is not associated with causing gynecological malignancies.
Diethylstilbestrol (DES): This synthetic estrogen was prescribed to pregnant women between the 1940s and 1970s to prevent miscarriages and other pregnancy complications. It has been linked to an increased risk of gynecological malignancies, such as clear cell adenocarcinoma of the vagina and cervix, in the daughters of women who took the drug.
In summary, Diethylstilbestrol is the medication known to cause gynecological malignancies in females.